|
|
Hello Nature readers, Today we explore a worrying bird flu infection, discover a squid-inspired drug-delivery device and brace ourselves for the final hours of COP29. |
|
|
The ill adolescent did not work or live on a poultry farm, and researchers have found no signs of H5N1 infection in household pets, leaving the source of their infection unclear. (Pictured is a coloured scanning electron micrography image of bird flu virus particles (pink) infecting a human cell (blue).) (Steve Gschmeissner/Science Photo Library) |
|
A teenager in Canada is in critical condition after being infected with a version of the H5N1 avian influenza virus that has researchers on high alert. Viral genome sequences suggest that this is a mutated form of H5N1 — which is related to the one infecting US dairy cattle but might be better at infecting the human airway. If true, it could mean that the virus can rapidly evolve to make the jump from birds to humans. “There is reason to be concerned,” says immunologist Scott Hensley. “But not reason to totally freak out.” Nature | 6 min read
|
|
Many university scientists are frustrated by the limited amount of computing power available to them for research into artificial intelligence (AI). Graphics processing units (GPUs) — computer chips often used to train AI models — can be prohibitively expensive for academics, which hinders their ability to develop large language models and conduct AI research. “The gap between academic and industry models is huge,” says Stella Biderman, executive director at non-profit AI research institute EleutherAI. Nature | 5 min read Reference: arXiv preprint (not peer reviewed)
|
|
A wave of academics and researchers have defected from the social media platform Twitter/X, with many heading to upstart Twitter-lookalike Bluesky. Part of the attraction is the ease of gathering worthy connections through moderated lists such as the Science feed and ‘starter packs’ of scientists to follow. “I’d really like it to continue to be a place of joy for me,” says bioacoustics researcher Daryll Carlson. Others say that, despite a rise in pornography, spam, bots and abusive content on Twitter, the platform remains a valuable tool for science communication. “If good experts quit X, who will offer evidence-based input on X?” asks tuberculosis researcher Madhukar Pai. Nature | 6 min read
|
|
QUESTION OF THE WEEKWhat do you think about the next steps for scientists on social media — should #ScienceTwitter become #ScienceSky? |
|
|
|
|
|
|
A physicist endures the anxiety of testing a time machine for a little longer than they’d hoped in I’ll burn this bridge when you get here, while seeing into the multiverse proves a burden in Epiphanies. Nature | 6 min read & Nature | 6 min read
|
|
Andrew Robinson’s pick of the top five science books to read this week includes an exploration of how climate change threatens geopolitics and an examination of the ‘snake oil’ tactics behind the public’s distorted understanding of AI. Nature | 3 min read
|
|
Modelled after squids’ ability to shoot ink, swallowable devices can deliver tiny jets of drugs directly into the gut lining, circumventing the need for needles. The devices protect drugs from degradation as they pass through the digestive system, an issue that currently prohibits drugs such as insulin from being given orally. In dogs and pigs, “the amount of insulin that we could deliver was comparable to the administration subcutaneously”, says biomedical engineer Giovanni Traverso. “I would say it's more than pretty good from a success perspective.” Nature Podcast | 29 min listen Subscribe to the Nature Podcast on Apple Podcasts, Spotify or YouTube Music, or use the RSS feed.
|
|
|
|
QUOTE OF THE DAY“I think it’s almost inevitable that, at least in my lifetime, there will be some version of an AI Fukushima.”Cancer researcher and Pulitzer Prize-winning author Siddhartha Mukherjee fears that the increasing use of AI in science might lead to disaster. (The Guardian | 5 min read) |
|
|
|
|
FREE NEWSLETTERS FROM NATUREWant more? Update your preferences to sign up to our other Nature Briefing newsletters:
Please visit your preferences page to choose which Nature Briefing newsletters to receive (or to unsubscribe). |
|
Nature+ is our most affordable 30-day subscription, giving you online access to a wide range of specialist Nature Portfolio journals, including Nature. Learn more about Nature+ |
|
|
|